Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Identification and functional characterization of novel murine DIS3L2 isoforms

Created on 24 Oct 2026

Authors

Cepeda, L. P. P., Queiroz, B. R. S., Tsantarlis, K., Gomes Neto, V., Maniero, L. H. S., Uscata, B. A., Goto, H., Oliveira, C. C.

Abstract

RNases are key factors for the posttranscriptional control of gene expression due to their involvement in processing, degradation and quality control of all classes of RNA in eukaryotes. DIS3L2 is an evolutionarily conserved exoribonuclease involved in cytoplasmic RNA degradation pathways that regulate gene expression. Macrophages undergo great change in gene expression of specific genes that allow these cells to perform multiple functions in addition to defense against infection. Here, we analyzed the change in expression of macrophages genes in response to Leishmania major infection, and show evidence that the levels of RNases such as the RNA exosome, XRN1, and DIS3L2, are modulated by the infection. We then identified three DIS3L2 variants that are differentially expressed in murine macrophages and other cell lines. DIS3L2 isoforms show similar RNA binding affinity, but differences in exonucleolytic activity in in vitro assays. Furthermore, we characterized the interactome of the DIS3L2 variants, which shows similarities with respect to ribosomal proteins, but differences that hint at specific functions for each isoform. This work uncovers previously uncharacterized DIS3L2 isoforms that are active, whose functions have yet to be identified.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 24 Oct 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement